The protein, known as QP509L, was investigated by a team of researchers at the College of Veterinary Medicine of Chungnam National University in Daejeon, Republic of Korea, led by corresponding author Jong-Soo Lee. Their work reveals that QP509L functions as what the authors describe as a dual-targeted molecular breaker of innate immunity. Rather than blocking a single immune pathway, the protein interferes both with the STING pathway, which detects viral DNA inside the cell, and with the JAK-STAT signaling axis, which carries the interferon alarm from the cell surface to the nucleus. The finding provides a mechanistic explanation for the remarkable ability of African swine fever virus to neutralize type I interferon responses, the body’s first chemical line of defense against viral infection.

To appreciate the significance of the discovery, it helps to understand how the two pathways work. When a virus replicates inside a cell, fragments of its DNA can leak into the cytoplasm, where they are detected by a sensor called cGAS. This sensor triggers the production of a small messenger molecule that activates STING, a protein resident on the endoplasmic reticulum. Once activated, STING must physically travel from the endoplasmic reticulum to the ER-Golgi intermediate compartment, a journey powered by the cell’s COPII vesicle transport machinery, before it can recruit and activate the kinases TBK1 and the transcription factor IRF3. Only after this trafficking step can the cell begin producing interferon, the soluble signal that warns neighboring cells that a virus is on the loose.

The Korean team found that QP509L shuts down this process at its most vulnerable juncture: the journey itself. Through detailed molecular interaction assays, they showed that QP509L binds to the C-terminal region of STING, a segment containing two specific amino acid residues, leucine 333 and arginine 334. This binding interferes with the association between STING and Sec24C, a core component of the COPII coat protein complex that loads cargo into transport vesicles. With Sec24C unable to engage STING properly, the activated sensor becomes stranded near the endoplasmic reticulum and cannot complete its anterograde trafficking to the ER-Golgi intermediate compartment. The consequence is a bottleneck that starves the downstream signaling machinery of its key activator.

The functional outcome of this trafficking blockade is exactly what one would predict. With STING immobilized, the recruitment and activation of TBK1 are diminished, and in turn the phosphorylation and activation of IRF3 are reduced, dampening the transcriptional program that drives interferon production. The researchers also observed that the trafficking defect altered STING-associated autophagic responses, suggesting that QP509L may interfere not only with interferon induction but also with the related cellular processes that help degrade viral components. In effect, the viral protein does not merely muffle the alarm; it prevents the alarm from ever being delivered to the right room in the first place.

But QP509L does not stop there. Even if a cell manages to produce some interferon, that signal must still be received and translated into action by neighboring cells, and this is where the second arm of the protein’s sabotage comes into play. Interferon binds to receptors on the cell surface and activates the JAK-STAT pathway, culminating in the phosphorylation of STAT1 at a specific tyrosine residue, tyrosine 701. Phosphorylated STAT1 teams up with STAT2 and a third protein called IRF9 to form a complex known as interferon-stimulated gene factor 3, or ISGF3. This complex travels into the nucleus and switches on hundreds of interferon-stimulated genes, the biochemical arsenal that renders cells resistant to viral replication.

The study demonstrates that QP509L targets this pathway as well, binding to the C-terminal transactivation domain of STAT1. By occupying this region, the viral protein reduces the phosphorylation of STAT1 at tyrosine 701, a modification that is essential for the assembly of the ISGF3 complex. With STAT1 insufficiently phosphorylated, the heterotrimeric ISGF3 complex fails to assemble properly and cannot be imported into the nucleus at normal levels. The result is that even when interferon is present in the extracellular environment, the cell’s genetic response to it is blunted, leaving the virus freer to replicate with less molecular resistance.

Perhaps the most compelling evidence for the physiological relevance of these findings comes from experiments performed during actual infection with a pathogenic strain of African swine fever virus. When the researchers used small interfering RNA to knock down QP509L expression during infection, the host cell’s antiviral gene expression was restored. This loss-of-function experiment demonstrates that QP509L is not merely capable of interfering with immune signaling in artificial overexpression systems; it actively performs this suppression during the course of a real infection, making it a genuine virulence factor rather than a laboratory curiosity.

The timing of QP509L’s expression adds an additional layer of interest. The gene is transcribed early during infection, yet the protein itself behaves as a late product. This temporal pattern suggests that the virus may stockpile the transcript in preparation for a later phase of the replication cycle, when large amounts of viral DNA accumulate in the cytoplasm and the STING pathway would otherwise be maximally triggered. By deploying its dual-function antagonist at precisely the moment when the cell’s DNA-sensing machinery and interferon amplification loop would converge, the virus ensures that both the sensor and the responder are neutralized in a coordinated fashion.

The implications for disease control are potentially significant. African swine fever has devastated pig populations across Asia, Europe, and beyond, and the absence of an effective vaccine owes much to the difficulty of attenuating a virus that carries so many overlapping immune evasion functions. By identifying QP509L as a central node in that evasion network, and by pinpointing the specific molecular interfaces it exploits, including the L333 and R334 residues on STING and the transactivation domain of STAT1, the study offers concrete targets for rational attenuation. A virus engineered to lack or disable QP509L would be expected to reveal itself far more readily to the innate immune system, a strategy that has proven successful for vaccine development against other pathogens. The authors propose QP509L as a promising candidate for such future attenuation strategies, and the open-access publication ensures that researchers worldwide can build on the finding. As the global swine industry continues to absorb the enormous economic costs of this disease, understanding the molecular saboteurs that make the virus so lethal represents an essential step toward the vaccines and therapeutics that farmers desperately need.

Subject of Research: Mechanism by which African swine fever virus protein QP509L suppresses STING and STAT1 innate immune signaling

Article Title: African swine fever virus QP509L acts as a dual-targeted molecular breaker of innate immunity by interfering with STING trafficking and STAT1-dependent signaling

Article References: Weerasinghe, D. S. D., Cha, J.-W., Wikramasinghe, A., Peiris, M. A. L. M., Rathnapala, P., Abesinghe, S., Dhananjani, Y., Weerawardhana, A., & Lee, J.-S. (2026). African swine fever virus QP509L acts as a dual-targeted molecular breaker of innate immunity by interfering with STING trafficking and STAT1-dependent signaling. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06484-8

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06484-8

Keywords: African swine fever virus, QP509L, innate immunity, STING, interferon, JAK-STAT, STAT1, ISGF3, COPII trafficking, antiviral defense, viral immune evasion, swine disease

The research team, led by Angelina Zimenko and Jia Zhu with colleagues at the University of Washington and the Fred Hutchinson Cancer Center, set out to examine a question that has been surprisingly underexplored. Interferon gamma is well established as a critical weapon in the antiviral arsenal of tissue-resident T cells, the immune sentinels that patrol mucosal surfaces and respond when HSV-2 attempts to reactivate from its latent state in sensory neurons. What has remained murky is how the target cells of that signal, the epithelial cells of the genital skin and mucosa, respond to it, and whether differences in that response could help explain why some people develop lesions while others do not.

To address this, the investigators worked with primary keratinocytes, the dominant epithelial cell type of the outer genital tissue, obtained from donors with well-characterized HSV-2 infection. Crucially, the donors fell into two clinically distinct groups: those with asymptomatic infection, who shed virus without developing lesions, and those with ulcerative disease, who experience recurrent genital sores. The researchers also isolated donor-matched fibroblasts, the structural cells of the underlying dermis, allowing them to compare epithelial and stromal responses within the same individual. This paired design gave the team a way to isolate cell-type-specific behavior from person-to-person variation.

The first major finding concerned sheer sensitivity. Keratinocytes turned out to be remarkably responsive to interferon gamma, altering their gene expression at concentrations far lower than those typically used in laboratory studies of the cytokine. This matters because the doses commonly employed in cell culture experiments have often been orders of magnitude higher than what immune cells are thought to deliver locally in tissue. By probing responses across a range of physiologically relevant interferon gamma concentrations, the researchers revealed that epithelial cells are tuned to detect and react to very faint cytokine signals, a property that previous work had substantially underestimated.

The comparison with fibroblasts sharpened the picture. Across donors, keratinocytes showed greater sensitivity to interferon gamma stimulation than their matched fibroblasts, and the epithelial response was dominated by robust induction of chemokines, the secreted proteins that act as homing beacons for circulating immune cells. Among these, CXCL10 stood out. It was the most sensitive and most strongly induced gene in the dataset, ramping up rapidly even at the lowest interferon gamma doses tested. CXCL10 is a well-known ligand for the chemokine receptor CXCR3, which is expressed on activated T cells and other immune populations, making it a plausible molecular bridge between cytokine signaling and the recruitment of antiviral lymphocytes to sites of viral reactivation.

The most clinically significant result emerged when the researchers compared keratinocytes from the two donor groups. Epithelial cells from individuals with asymptomatic HSV-2 infection mounted significantly stronger responses to interferon gamma than cells from donors with ulcerative disease, and the difference was most pronounced at the low, physiologically relevant cytokine concentrations. The heightened responsiveness was evident both at the messenger RNA level and at the protein level, indicating that the cells from asymptomatic donors were not merely transcribing chemokine genes more vigorously but actually secreting more of the corresponding proteins. In effect, the epithelial barrier of people who never develop lesions appeared intrinsically better wired to broadcast an immune-recruitment alarm when interferon gamma arrives.

Delving into the signaling machinery, the team found that the enhanced response correlated with increased nuclear localization of phosphorylated STAT1, the transcription factor that carries the interferon gamma signal from the cell surface receptor into the nucleus. Interestingly, this difference was not explained by higher baseline expression of the interferon gamma receptor or of STAT1 itself, which were similar across donor groups. Instead, the asymptomatic donors’ keratinocytes appeared to process the incoming signal more efficiently, amplifying the downstream transcriptional output. This suggests that the variation lies in the dynamics of the JAK-STAT signaling pathway rather than in the simple abundance of its components, a distinction that could guide future mechanistic studies of interferon responsiveness in epithelial barriers.

An important nuance concerns the direct antiviral effect of the cytokine. When the researchers pretreated keratinocytes with interferon gamma before exposing them to HSV, the cytokine suppressed viral replication to a similar degree in cells from both donor cohorts. In other words, the intrinsic antiviral state that interferon gamma induces in epithelial cells was not obviously stronger in the asymptomatic group. What differed was the chemokine output. The authors propose, therefore, that the advantage enjoyed by asymptomatic individuals may lie less in the epithelium’s ability to block the virus directly and more in its capacity to summon antiviral immune cells to the tissue through vigorous chemokine production, particularly CXCL10, thereby containing reactivation events before they escalate into visible lesions.

Taken together, the findings reframe the epithelium as an active participant in the immunology of genital herpes rather than a passive substrate for viral replication. Tissue-resident T cells clearly supply the interferon gamma signal, but the study indicates that the clinical outcome of that signal depends on how loudly the epithelial target cells answer. Intrinsic variation in epithelial interferon gamma responsiveness emerges as a candidate host factor associated with whether HSV-2 infection runs a symptomatic or silent course, and CXCL10-mediated immune recruitment is highlighted as a key mechanism potentially linking T cell cytokine signaling to epithelial antiviral defense. The researchers caution that their work identifies an association and a plausible mechanism, and that establishing causation in human infection will require further study.

The implications extend beyond basic virology. Therapeutic vaccines for genital herpes, which aim to boost T cell responses in the genital tract, implicitly rely on the responsiveness of target tissues to the cytokines those T cells produce. If a substantial fraction of the population has epithelial cells that respond weakly to interferon gamma, strategies that amplify chemokine signaling or sensitize the JAK-STAT pathway in epithelial cells could complement vaccine approaches. Conversely, measuring epithelial interferon gamma responsiveness might eventually help stratify patients by their likelihood of symptomatic disease. As the authors note, understanding variability in the immune defenses of the epithelial barrier may prove crucial for improving both therapies and vaccine strategies against one of the world’s most prevalent chronic infections.

Subject of Research: Epithelial interferon gamma signaling and chemokine responses in herpes simplex virus type 2 infection outcomes

Article Title: Epithelial interferon-γ responsiveness shapes chemokine induction and clinical outcomes in herpes simplex virus infection

Article References: Zimenko, A., Hayman, I., Fong, Y., Monroe, L. D., Mills, M. G., Greninger, A., Johnston, C., Corey, L., & Zhu, J. (2026). Epithelial interferon-γ responsiveness shapes chemokine induction and clinical outcomes in herpes simplex virus infection. PLOS Pathogens, 22(9), e1014612. https://doi.org/10.1371/journal.ppat.1014612

Image Credits: AI Generated

DOI: 10.1371/journal.ppat.1014612

Keywords: HSV-2, genital herpes, interferon gamma, keratinocytes, CXCL10, chemokines, STAT1, tissue-resident T cells, epithelial immunity, viral reactivation, PLOS Pathogens, antiviral defense

The authors argue that the core of viral infection lies in the intricate interaction network between viral proteins and host proteins. As obligate intracellular parasites, plant viruses carry compact genomes encoding only a handful to a few dozen proteins, and they depend extensively on host factors to accomplish entry, replication, assembly, movement and release of progeny virions. Crucially, these interactions also serve as molecular interfaces linking infection to plant defense. Many viral proteins physically interact with key components of the salicylic acid, jasmonic acid and abscisic acid signaling pathways, often suppressing host immunity to promote infection, while plants can exploit specific interactions as molecular cues to activate immune signaling and restrict viral spread. This bidirectional character makes protein interactions simultaneously virulence factors and defense regulators.

A substantial portion of the review is devoted to the technical arsenal available for detecting these interactions. Biophysical techniques such as microscale thermophoresis, isothermal titration calorimetry and biolayer interferometry quantify binding affinities with high sensitivity, minimal sample volumes and low false-positive rates. Microscale thermophoresis monitors the thermophoretic movement of fluorescently labeled proteins across a temperature gradient, and is particularly useful for proteins that are difficult to express or unstable. Isothermal titration calorimetry directly yields full thermodynamic profiles, including enthalpy, entropy and Gibbs free energy, without the need for labeling. Biolayer interferometry measures binding-induced shifts in the interference pattern of light reflected from fiber-optic biosensors, enabling real-time observation of association and dissociation kinetics, and has been applied to quantify binding between viral effectors and host receptors.

Biochemical and cell-based methods complement these quantitative approaches. Co-immunoprecipitation examines interactions in their natural state inside cells, whereas GST pull-down assays test direct bait-prey interactions in vitro, albeit with the risk of tag-induced nonspecific binding. Bimolecular fluorescence complementation reconstitutes a fluorescent protein from two nonfluorescent fragments fused to the proteins of interest, allowing direct visualization of interactions in living cells, though the technique is notoriously temperature sensitive and can fail at higher physiological temperatures. On the computational side, databases such as STRING and Pfam integrate experimental evidence, domain annotations and literature data to predict and visualize interaction networks, providing structural and functional context for experimentally detected pairs.

The review highlights the growing dominance of mass spectrometry-based proteomics in interaction discovery. By the end of 2023, the BioGRID database had compiled more than 2.63 million protein interaction entries, with mass spectrometry techniques such as affinity capture-MS, proximity labeling-MS and co-fractionation collectively contributing over 45 percent of the data. Affinity purification coupled with mass spectrometry remains the predominant high-throughput method, but it struggles with membrane proteins and transient or weak interactions. Proximity labeling overcomes these limits by biotinylating proteins near a target of interest in living cells; the engineered ligases TurboID and miniTurbo, developed through directed evolution, achieve substantial biotinylation within ten minutes, dramatically shortening experimental timelines. Cofractionation mass spectrometry infers interactions from co-elution during chromatographic separation, while chemical cross-linking mass spectrometry captures direct physical contacts by covalently linking proximal amino acid residues, providing distance constraints for structural modeling. The lysis-free Virotrap method, which packages bait proteins into virus-like particles to capture associated host factors under near-native conditions, further reduces purification artifacts.

Despite these advances, the authors caution that no single method suffices. Mass spectrometry generates vast datasets that demand sophisticated processing, and variability in protein abundance complicates detection of low-abundance interactors. Protein interactions are inherently transient, low-affinity and dynamic, varying across tissues, developmental stages and infection time points. Artificial intelligence tools such as AlphaFold and RoseTTAFold have accelerated structure-based prediction of interactions, but their accuracy depends heavily on the quality of multiple sequence alignments and they perform poorly on orphan proteins and complexes with limited homologous sequences. The review therefore advocates an integrative, dynamic and network-centric strategy combining in vitro, in vivo and computational approaches.

The mechanistic core of the review documents how viruses manipulate host proteins at nearly every regulatory layer. RNA silencing is a central antiviral defense in plants, and viruses counter it with dedicated suppressors. The 38 kDa coat protein of turnip crinkle virus interacts with SGS3 to enhance its suppressor activity; the p19 protein of tomato bushy stunt virus sequesters small interfering RNAs and prevents their incorporation into the RNA-induced silencing complex; and the F-box protein P0 of potato leafroll virus promotes the autophagic degradation of ARGONAUTE1. Beyond post-transcriptional silencing, the P3 protein of rice grassy stunt virus triggers P3IP1- and SERK4-dependent degradation of NRPD1a, the largest subunit of RNA polymerase IV, thereby suppressing RNA-directed DNA methylation. A plant bunyaviral protein has also been shown to disrupt the phase separation of SERRATE, dismantling dicing bodies and reducing microRNA biogenesis.

Viruses likewise target signaling cascades and cellular quality-control systems. The coat protein of beet black scorch virus suppresses MAPKKKα-mediated innate immunity through interaction with 14-3-3a, while the βC1 protein of cotton leaf curl Multan virus inhibits MKK2 and MPK4. The NIb protein of turnip mosaic virus blocks SUMOylation-dependent phosphorylation of the salicylic acid receptor NPR1, and the P2 capsid protein of rice dwarf virus competes with the auxin receptor OsTIR1 for binding to OsIAA10, rewiring auxin signaling to promote symptoms. Tobacco mosaic virus coat protein suppresses the calmodulin-like protein NbCML30, and the RNA-dependent RNA polymerases of cucumber mosaic virus, potato virus Y and tobacco mosaic virus disrupt the phyA-FHY1 interaction to impair far-red light-mediated immunity. Autophagy is another contested hub: the γb protein of barley stripe mosaic virus interferes with the ATG7-ATG8 interaction, while the host receptor NBR1 mediates autophagic degradation of turnip mosaic virus HCpro, which the virus counteracts through VPg and 6K2.

Viruses also co-opt host machinery for replication and movement. Potyviruses use their genome-linked VPg protein to mimic a cap structure and recruit translation initiation factors of the eIF4E family, with different potyviruses requiring different eIF4E isoforms in different hosts. The conserved chaperone HSP70 supports the assembly of tomato bushy stunt virus replication complexes on peroxisomal membranes and the cell-to-cell movement of abutilon mosaic virus, and silencing HSP70 attenuates symptoms. Translationally controlled tumor protein supports potyvirus multiplication, and its silencing in tobacco nearly abolishes potato virus Y symptoms. Conversely, plants deploy sensors and resistance proteins: the E3 ubiquitin ligase RBRL recognizes the coat proteins of rice stripe virus and rice dwarf virus to activate jasmonate-mediated immunity; the tomato Tm-22 and Sw-5b immune receptors recognize viral movement proteins; the RTM genes restrict phloem-based systemic movement of potyviruses; and host kinases such as PKA and CK2 phosphorylate viral proteins to impair their function.

These insights are now feeding directly into crop protection. The review outlines how interaction maps distinguish susceptibility genes, which encode host factors hijacked by viruses, from resistance genes, which mediate immune recognition, enabling targeted genome editing of the former and overexpression of the latter. CRISPR/Cas systems have been used both to cleave viral genomes, as demonstrated for geminiviruses and, using FnCas9 and Cas13a, for RNA viruses such as cucumber mosaic virus and tobacco mosaic virus, and to edit host factors such as the cassava eIF4E-family proteins nCBP-1 and nCBP-2 that interact with cassava brown streak virus VPg. In a striking example of precision editing, base editing of a single residue in the rice strigolactone receptor D14 abolished binding by the rice grassy stunt virus P3 protein while preserving hormone perception, conferring robust resistance in both japonica and indica rice. The authors conclude that integrating interactome mapping, AI-assisted structural prediction and CRISPR-based functional validation offers a rational path toward broad-spectrum, durable virus resistance, while warning that single-point edits can be bypassed by viral mutation and that plant virus interaction databases remain far less mature than their animal-virus counterparts, underscoring the need for sustained, systematic data generation.

Subject of Research: Virus-host protein-protein interactions and their role in plant antiviral defense and crop resistance breeding

Article Title: The multidimensional significance of virus-host protein interactions and their implications in the antiviral defense of plants

Article References: Zhang, J., Qi, C., Wu, Z., Zhang, Y., Shi, J., Li, Z., Guo, J., Zhou, X., Tang, S., Yang, J., & Liu, P. (2026). The multidimensional significance of virus-host protein interactions and their implications in the antiviral defense of plants. Stress Biology, 6(1), Article 39. https://doi.org/10.1007/s44154-026-00309-1

Image Credits: AI Generated

DOI: 10.1007/s44154-026-00309-1

Keywords: plant viruses, protein-protein interactions, antiviral defense, RNA silencing, mass spectrometry, proximity labeling, AlphaFold, CRISPR, susceptibility genes, resistance genes, crop breeding, phytohormone signaling